Access to Unsymmetrical Alkylmalonic Ester Derivatives
3-(2-Br om op r op ion yl)-4S-ben zyl-2-oxa zolid in on e 1f.20
3-(2-Meth oxyca r bon ylp r op ion yl)-4S-ben zyl-2-oxa zoli-
d in on e 2f + 2′f (Mixtu r e of Tw o Isom er s). More abundant
4.47 (dd, AB, 1H, J AB ) 12.5 HZ, J ) 2.6 Hz, ∆ν ) 44.9 Hz),
4.32 (q, 1H, J ) 6.8 Hz), 4.24 (dd, AB, 1H, J AB ) 12.5 Hz, J )
2.6 Hz, ∆ν ) 44.9 Hz), 1.74 (d, 3H, J ) 6.8 Hz), 1.41 (s, 3H),
1.33 (s, 3H); 13C NMR δ (CDCl3) 173.2, 169.0, 113.7, 79.3, 77.5,
75.1, 64.6, 39.0, 26.6, 25.4, 21.4; GC-MS m/z (M•+ absent) 309
(M+ + 2 - CH3, 21), 307 (M+ - CH3, 23), 109 (13), 107 (14),
1
isomer: H NMR δ (CDCl3) 7.33-7.14 (m, 5H), 4.75-4.62 (m,
1H), 4.50 (q, 1H, J ) 7.2 Hz), 4.27-4.02 (m, 2H), 3.71 (s, 3H),
3.38-3.21 (m, 1H), 2.81-2.70 (m, 1H), 1.45 (d, 3H, J ) 7.2
Hz); 13C NMR δ (CDCl3) 170.8, 169.3, 153.2, 135.2, 129.3,
128.8, 127.2, 66.2, 55.3, 52.4, 45.4, 37.2, 13.1; GC-MS m/z 291
(M•+, 4), 260 (M+ - OCH3, 5), 115 (100), 91 (34), 59 (44). Less
abundant isomer: 1H NMR δ (CDCl3) 7.33-7.14 (m, 5H), 4.75-
4.62 (m, 1H), 4.54 (q, 1H, J ) 7.2 Hz), 4.27-4.02 (m, 2H), 3.68
(s, 3H), 3.38-3.21 (m, 1H), 2.81-2.70 (m, 1H), 1.46 (d, 3H, J
) 7.2 Hz); 13C NMR δ (CDCl3) 170.7, 169.6, 153.3, 134.9, 129.4,
128.8, 127.3, 66.4, 55.1, 52.4, 45.4, 37.7, 13.2; GC-MS m/z 291
(M•+, 4), 260 (M+ - OCH3, 5), 115 (100), 91 (34), 59 (44).
4S-Ben zyl-3-p r op ion yl-2-oxa zolid in on e 3f: commercial.
3-(2-Br om op r op ion yl)-4S-isop r op yl-2-oxa zolid in on e 1g
(Both Isom er s).20
3-(2-Met h oxyca r b on ylp r op ion yl)-4S-isop r op yl-2-ox-
a zolid in on e 2 g+2′g (Mixtu r e of Tw o Isom er s). More
abundant isomer: 1H NMR δ (CDCl3) 4.59-4.39 (m, 2H), 4.34-
4.10 (m, 2H), 3.69 (s, 3H), 2.52-2.30 (m, 1H), 1.42 (d, 3H, J )
7.2 Hz), 0.93 (s, 3H), 0.89 (s, 3H); 13C NMR δ (CDCl3) 170.9,
169.2, 154.0, 63.6, 58.6, 52.4, 45.5, 28.2, 17.8, 14.5, 13.1; GC-
MS m/z (M•+ absent) 212 (M+ - OCH3, 7), 200 (M+ - iPr, 4),
115 (100), 87 (21), 59 (32). Less abundant isomer:1H NMR δ
(CDCl3) 4.59-4.39 (m, 2H), 4.34-4.10 (m, 2H), 3.69 (s, 3H),
2.52-2.30 (m, 1H), 1.42 (d, 3H, J ) 7.2 Hz), 0.93 (s, 3H), 0.89
(s, 3H); 13C NMR δ (CDCl3) 170.9, 169.2, 154.0, 63.6, 58.6, 52.4,
45.5, 28.4, 17.8, 14.7, 13.4; GC-MS m/z (M•+ absent) 212 (M+
- OCH3, 6), 200 (M+ - iPr, 4), 115 (100), 87 (16), 59 (28).
4S-Isop r op yl-3-p r op ion yl-2-oxa zolid in on e 3g: commer-
cial.
43 (100); [R]20 ) -20.9 (c ) 0.52, AcOEt). Anal. Calcd for
D
C
11H15BrO6: C, 40.89; H, 4.68. Found: C, 40.93; H, 4.70.
2,3-O-Isop r op ylid en e-γ-D-r ibon ola cton e 2-br om op r o-
p ion a te 1i (less p ola r isom er ): 1H NMR δ (CDCl3) 4.91 (d,
AB, 1H, J AB ) 5.6 Hz, ∆ν ) 43.6.1 Hz), 4.69 (app d, AB, 1H,
J AB ) 5.6 Hz, ∆ν ) 43.6 Hz), 4.77 (dd, 1H, J ) 2.2, 2.2 Hz),
4.37 (d, 2H, J ) 2.2 Hz), 4.33 (q, 1H, J ) 6.8 Hz), 1.78 (d, 3H,
J ) 6.8 Hz), 1.44 (s, 3H), 1.36 (s, 3H); 13C NMR δ (CDCl3) 173.3,
169.2, 113.8, 79.4, 77.6, 75.2, 64.8, 38.8, 26.6, 25.5, 21.2; GC-
MS m/z: (M•+ absent) 309 (M+ + 2 - CH3, 54), 307 (M+
-
CH3, 63), 109 (13), 107 (14), 43 (100); [R]•+ ) -25.0 (c ) 0.83,
AcOEt). Anal. Calcd for
Found: C, 4.90; H, 4.69.
C11H15BrO6: C, 40.89; H, 4.68.
2,3-O-Isop r op ylid en e-γ-D-r ibon ola cton e 2-Meth oxyca r -
bon ylp r op ion a te 2i + 2′i (Mixtu r e of Tw o Isom er s). More
abundant isomer: 1H NMR δ (CDCl3) 4.80-4.21 (m, 5H), 3.72
(s, 3H), 3.43 (q, 1H, J ) 7.2 Hz), 1.45 (s, 3H), 1.38 (d, 3H, J )
0.2 Hz), 1.36 (s, 3H); 13C NMR δ (CDCl3) 173.4, 169.7, 168.8,
113.8, 79.5, 75.1, 64.3, 52.9, 45.9, 29.6, 26.7, 25.6, 13.6; GC-
MS m/z (M•+ absent) 287 (M+ - CH3, 23), 307 (M+ - CH3, 63),
1
213 (6), 115 (76), 59 (75), 43 (100). Less abundant isomer: H
NMR δ (CDCl3) 4.80-4.21 (m, 5H), 3.71 (s, 3H), 3.43 (q, 1H, J
) 7.2 Hz), 1.45 (s, 3H), 1.40 (d, 3H, J ) 0.2 Hz), 1.36 (s, 3H);
13C NMR δ (CDCl3) 173.3, 170.0, 169.0, 113.8, 79.4, 75.1, 64.3,
52.8, 45.7, 29.6, 26.7, 25.5, 13.4; GC-MS m/z (M•+ absent) 287
(M+ - CH3, 23), 307 (M+ - CH3, 63), 213 (6), 115 (76), 59 (75),
43 (100).
N-[(5R)-10,10-Dim eth yl-3,3-d ioxo-3-th ia -4-a za tr icyclo-
[5.2.1.01,5]d ec-4-yl]-2-br om op r op ion a m id e 1j (Both Iso-
m er s).25
3-(2-Br om opr opion yl)-(4R,5S)-in dan o[1,2-d]oxazolidin -
2-on e 1h (isola ted on ly on e isom er ): 1H NMR δ (CDCl3)
7.62-7.59 (m, 1H), 7.38-7.22 (m, 3H), 5.92 (d, 1H, J ) 6.8
Hz), 5.68 (q, 1H, J ) 6.7 Hz), 5.33 (dt, 1H, J ) 6.8 Hz, J ) 3.5
Hz), 3.38 (d, 2H, J ) 3.3 Hz), 1.84 (d, 3H, J ) 6.7 Hz); 13C
NMR δ (CDCl3) 170.1, 152.1, 139.5, 138.6, 130.1, 128.3, 127.2,
125.3, 78.5, 63.7, 38.5, 37.8, 20.8; GC-MS m/z 311 (M•+ + 2,
N-[(5R)-10,10-Dim eth yl-3,3-d ioxo-3-th ia -4-a za tr icyclo-
[5.2.1.01,5]d ec-4-yl]-2-m eth oxyca r bon ylp r op ion a m id e 2j′
(m or e a bu n d a n t, less p ola r isom er ): 1H NMR δ (CDCl3)
4.05 (q, 1H, J ) 7.1 Hz), 3.85 (dd, 1H, J ) 7.5, 5.1 Hz), 3.66
(s, 3H), 3.47 (d, AB, 1H, J ) 13.8 Hz, ∆ν ) 12.09 Hz), 3.41 (d,
AB, 1H, J ) 13.8 Hz, ∆ν ) 12.09 Hz), 2.12-1.79 (m, 5H), 1.40
(d, 3H, J ) 7.1 Hz), 1.38-1.25 (m, 2H), 1.35 (s, 3H), 0.93 (s,
3H); 13C NMR δ (CDCl3) 170.2, 168.0, 65.1, 52.9, 52.4, 48.5,
47.8, 45.9, 44.5, 37.8, 32.7, 26.4, 20.2, 19.9, 13.2; GC-MS m/z
(M•+ absent) 298 (M+ - OCH3, 10), 214 (14), 115 (100), 87 (40),
20
16%) 309 (M+, 17%), 230 (62%), 115 (100%). [R]D ) -206.5
(c ) 0.77, AcOEt). Anal. Calcd. for C13H12BrNO3: C, 50.34; H,
3.90; N, 4.52. Found: C, 50.51; H, 3.94; N, 4.61.
3-(2-Meth oxyca r bon ylp r op ion yl)-(4R,5S)-in d a n o[1,2-d ]-
oxa zolid in -2-on e 2h or 2′h (m or e p ola r isom er ): 1H NMR
δ (CDCl3) 7.62-7.59 (m, 1H), 7.37-7.27 (m, 3H), 5.97 (d, 1H,
J ) 6.8 Hz), 5.29 (dt, 1H, J ) 6.8, 3.4 Hz), 4.52 (q, 1H, J ) 7.2
Hz), 3.57 (s, 3H), 3.37 (d, 2H, J ) 3.4 Hz), 1.48 (d, 3H, J ) 7.2
Hz); 13C NMR δ (CDCl3) 170.6, 170.0, 152.8, 139.2, 138.6,
129.9, 128.1, 127.2, 125.1, 78.6, 63.1, 52.3, 45.3, 37.8, 13.2;
GC-MS m/z (M•+ absent) 258 (M+ - OCH3, 7), 245 (M+ - CO2,
59 (95); [R]20 ) -77.9 (c ) 0.68, AcOEt). Anal. Calcd for
D
C
15H23NO5S: C, 54.69; H, 7.04; N, 4.25. Found: C, 54.73; H,
7.10; N, 4.20.
This isomer was identified as the (2R) compound, and this
assignment is supported by an X-ray crystallographic structure
determination.
17), 174 (5), 130 (100), 115 (65); [R]20 ) -85.1 (c ) 0.47,
D
AcOEt). Anal. Calcd for C15H15NO5: C, 62.28; H, 5.23; N, 4.84.
Found: C, 62.41; H, 5.27; N, 4.90.
N-[(5R)-10,10-Dim eth yl-3,3-d ioxo-3-th ia -4-a za tr icyclo-
[5.2.1.01,5]d ec-4-yl]-2-m eth oxyca r bon ylp r op ion a m id e 2j
(less a bu n d a n t, m or e p ola r isom er in m ixtu r e w ith less
p ola r isom er ): 1H NMR δ (CDCl3) 4.07 (q, 1H, J ) 7.1 Hz),
3.92 (t, 1H, J ) 6.4 Hz), 3.71 (s, 3H), 3.50 (d, AB, 1H, J ) 13.9
Hz, ∆ν ) 8.57 Hz), 3.46 (d, AB, 1H, J ) 13.9 Hz, ∆ν ) 8.57
Hz), 2.12-1.79 (m, 5H), 1.44 (d, 3H, J ) 7.1 Hz), 1.38-1.25
(m, 2H), 1.21 (s, 3H), 0.94 (s, 3H); 13C NMR δ (CDCl3): 169.8,
169.3, 65.3, 52.9, 52.5, 48.5, 47.8, 46.2, 44.6, 38.2, 32.8, 26.4,
20.8, 19.8, 14.8; GC-MS m/z (M•+ absent) 298 (M+ - OCH3,
18), 214 (19), 115 (80), 87 (40), 59 (100).
N-[(5R)-10,10-Dim eth yl-3,3-d ioxo-3-th ia -4-a za tr icyclo-
[5.2.1.01,5]d ec-4-yl]-2-br om obu tyr a m id e 1k (less p ola r
isom er ): 1H NMR δ (CDCl3) 4.74 (t, 1H, J ) 7.2 Hz), 3.91
(dd, 1H, J ) 6.9, 5.6 Hz), 3.50 (d, AB, 1H, J ) 13.8 Hz, ∆ν )
15.12 Hz), 3.43 (d, AB, 1H, J ) 13.8 Hz, ∆ν ) 15.12 Hz), 2.23-
1.88 (m, 6H), 1.45-1.23 (m, 3H), 1.17 (s, 3H), 1.00 (t, 3H, J )
3-(2-Meth oxyca r bon ylp r op ion yl)-(4R,5S)-in d a n o[1,2-d ]-
oxa zolid in -2-on e 2h or 2′h (less p ola r isom er ): 1H NMR δ
(CDCl3) 7.60-7.57 (m, 1H), 7.37-7.24 (m, 3H), 5.97 (d, 1H, J
) 6.9 Hz), 5.33 (dt, 1H, J ) 6.9, 3.1 Hz), 4.54 (q, 1H, J ) 7.2
Hz), 3.72 (s, 3H), 3.38 (d, 2H, J ) 3.1 Hz), 1.45 (d, 3H, J ) 7.2
Hz); 13C NMR δ (CDCl3): 170.9, 170.1, 153.0, 139.4, 138.9,
130.0, 128.23, 127.1, 125.2, 78.3, 63.2, 52.5, 45.3, 38.0, 13.3;
GC-MS m/z (M•+ absent) 258 (M+ - OCH3, 7), 245 (M+ - CO2,
17), 174 (5), 130 (100), 115 (65); [R]20 ) -200.0 (c ) 0.87,
D
AcOEt). Anal. Calcd for C15H15NO5: C, 62.28; H, 5.23; N, 4.84.
Found: C, 62.39; H, 5.31; N, 4.87.
3-P r opion yl-(4R,5S)-in dan o[1,2-d]oxazolidin -2-on e 3h .24
2,3-O-Isop r op ylid en e-γ-D-r ibon ola cton e 2-br om op r o-
p ion a te 1i (m or e p ola r isom er ): 1H NMR δ (CDCl3) 4.89
(d, AB, 1H, J AB ) 5.6 Hz, ∆ν ) 38.1 Hz), 4.69 (app. d, AB, 1H,
J AB ) 5.6 Hz, ∆ν ) 38.1 Hz), 4.75 (dd, 1H, J ) 2.5, 2.5 Hz),
(25) Csuk, R.; Schro¨der, C.; Krieger, C. Tetrahedron 1997, 53 (38),
12947-12960.
(24) Ho, G.-J .; Mathre, D. J . J . Org. Chem. 1995, 60, 2271-2273.
J . Org. Chem, Vol. 69, No. 2, 2004 493